This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Université De Limoges, Centre National De La Recherche Scientifique-Cnrs, Chu Nantes. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Vincent Sol: Patents in Therapeutics and Selective Herbicides.
Introduction
Vincent Sol is an inventor based in Limoges, France. His patent work spans biomedical materials and agricultural chemistry, with applications ranging from peripheral neuropathy treatment to selective weed control.
Latest Patents
Sol’s listed patent portfolio includes 3 patents.
“Therapeutic Potential of Cellulose-Cyclodextrin-Curcumin Nanocrystals in the Treatment of Peripheral Neuropathies” describes a complex combining cellulose nanocrystals, β-cyclodextrin, and curcumin for potential use in treating peripheral neuropathies. The disclosure also covers pharmaceutical compositions containing the complex and possible delivery formats, including hydrogels, subcutaneous implants, implantable pumps, and biofunctionalized nerve conduits. These approaches are intended to support treatment compliance, extended release, and improved pharmacokinetics.
“Use of Cationic Porphyrins as Selective Herbicide” concerns the use of cationic porphyrins, including zinc tetra(N-methylpyridyl)porphyrin tetrachloride and tetra(N-methylpyridyl)porphyrin tetrachloride, as selective foliar herbicides.
Career Highlights
Sol’s listed organizational affiliations include Université de Limoges and the French Alternative Energies and Atomic Energy Commission, known as CEA. His patent topics reflect research with potential applications in both healthcare and agriculture.
Collaborations
His listed collaborators include Martial Caillaud and Robert Granet. Their names are associated with the collaborative research represented in Sol’s patent record.
Conclusion
Vincent Sol’s two listed patents illustrate an inventive portfolio connecting therapeutic materials for peripheral neuropathies with selective herbicidal applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile